Free Trial

Cryoport (CYRX) Competitors

Cryoport logo
$5.48 -0.10 (-1.70%)
As of 12:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CYRX vs. ARDX, DYN, AUPH, SNDX, BGM, ADPT, IOVA, WVE, ETNB, and COLL

Should you be buying Cryoport stock or one of its competitors? The main competitors of Cryoport include Ardelyx (ARDX), Dyne Therapeutics (DYN), Aurinia Pharmaceuticals (AUPH), Syndax Pharmaceuticals (SNDX), Qilian International Holding Group (BGM), Adaptive Biotechnologies (ADPT), Iovance Biotherapeutics (IOVA), Wave Life Sciences (WVE), 89bio (ETNB), and Collegium Pharmaceutical (COLL). These companies are all part of the "pharmaceutical products" industry.

Cryoport vs.

Ardelyx (NASDAQ:ARDX) and Cryoport (NASDAQ:CYRX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, community ranking, media sentiment and institutional ownership.

Ardelyx presently has a consensus price target of $10.61, suggesting a potential upside of 91.36%. Cryoport has a consensus price target of $11.67, suggesting a potential upside of 112.70%. Given Cryoport's higher probable upside, analysts plainly believe Cryoport is more favorable than Ardelyx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ardelyx
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.00
Cryoport
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Ardelyx has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500. Comparatively, Cryoport has a beta of 1.81, indicating that its share price is 81% more volatile than the S&P 500.

58.9% of Ardelyx shares are owned by institutional investors. Comparatively, 92.9% of Cryoport shares are owned by institutional investors. 5.9% of Ardelyx shares are owned by insiders. Comparatively, 10.1% of Cryoport shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Ardelyx had 8 more articles in the media than Cryoport. MarketBeat recorded 10 mentions for Ardelyx and 2 mentions for Cryoport. Ardelyx's average media sentiment score of 1.06 beat Cryoport's score of 0.58 indicating that Ardelyx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ardelyx
5 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cryoport
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ardelyx has a net margin of -11.73% compared to Cryoport's net margin of -70.08%. Cryoport's return on equity of -13.35% beat Ardelyx's return on equity.

Company Net Margins Return on Equity Return on Assets
Ardelyx-11.73% -24.87% -10.51%
Cryoport -70.08%-13.35%-6.43%

Ardelyx received 286 more outperform votes than Cryoport when rated by MarketBeat users. Likewise, 67.46% of users gave Ardelyx an outperform vote while only 65.88% of users gave Cryoport an outperform vote.

CompanyUnderperformOutperform
ArdelyxOutperform Votes
537
67.46%
Underperform Votes
259
32.54%
CryoportOutperform Votes
251
65.88%
Underperform Votes
130
34.12%

Ardelyx has higher revenue and earnings than Cryoport. Ardelyx is trading at a lower price-to-earnings ratio than Cryoport, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ardelyx$333.62M3.96-$39.14M-$0.16-34.66
Cryoport$228.39M1.20-$99.59M-$2.49-2.20

Summary

Ardelyx beats Cryoport on 12 of the 19 factors compared between the two stocks.

Get Cryoport News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYRX vs. The Competition

MetricCryoportPharmaceutical IndustryTransportation SectorNASDAQ Exchange
Market Cap$273.76M$6.72B$287.30B$7.97B
Dividend YieldN/A3.05%4.03%4.23%
P/E Ratio-1.627.3613.1518.58
Price / Sales1.20241.71212.49103.15
Price / Cash16.9565.8511.5434.62
Price / Book0.586.481.794.26
Net Income-$99.59M$143.43M$515.10M$248.31M
7 Day Performance-6.88%1.69%-0.17%1.34%
1 Month Performance-9.93%6.58%-1.23%3.92%
1 Year Performance-67.37%-2.63%-9.90%5.33%

Cryoport Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYRX
Cryoport
2.3918 of 5 stars
$5.49
-1.7%
$11.67
+112.7%
-65.5%$273.76M$228.39M-1.621,020Earnings Report
News Coverage
Gap Up
ARDX
Ardelyx
4.5603 of 5 stars
$4.56
-5.4%
$10.61
+132.7%
-13.9%$1.09B$333.62M-28.5090Positive News
DYN
Dyne Therapeutics
3.3281 of 5 stars
$9.33
+14.2%
$47.46
+408.7%
-53.4%$1.06BN/A-2.62100Short Interest ↑
High Trading Volume
AUPH
Aurinia Pharmaceuticals
2.6538 of 5 stars
$7.66
-1.2%
$11.50
+50.1%
+61.9%$1.05B$235.13M-51.06300Positive News
SNDX
Syndax Pharmaceuticals
3.6507 of 5 stars
$11.93
+3.4%
$36.20
+203.4%
-33.0%$1.03B$23.68M-3.29110Upcoming Earnings
Positive News
BGM
Qilian International Holding Group
N/A$10.52
-4.4%
N/AN/A$1.02B$25.10M0.00298
ADPT
Adaptive Biotechnologies
4.1445 of 5 stars
$6.83
-6.8%
$9.40
+37.6%
+180.9%$1.01B$178.96M-6.27790News Coverage
Positive News
IOVA
Iovance Biotherapeutics
4.5644 of 5 stars
$3.08
+0.7%
$18.22
+491.6%
-69.5%$1.01B$164.07M-2.07500Upcoming Earnings
Positive News
WVE
Wave Life Sciences
4.3104 of 5 stars
$6.12
+3.4%
$22.18
+262.4%
+56.6%$939.33M$108.30M-5.51240Upcoming Earnings
Analyst Forecast
Analyst Revision
News Coverage
ETNB
89bio
2.8306 of 5 stars
$6.27
+3.5%
$27.56
+339.5%
-5.8%$915.32MN/A-2.1540Upcoming Earnings
Analyst Upgrade
News Coverage
Positive News
COLL
Collegium Pharmaceutical
4.044 of 5 stars
$26.91
-0.4%
$43.60
+62.0%
-26.9%$864.67M$631.45M11.60210Upcoming Earnings
Positive News

Related Companies and Tools


This page (NASDAQ:CYRX) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners